To include your compound in the COVID-19 Resource Center, submit it here.

Pfizer to acquire Icagen

Pfizer Inc. (NYSE:PFE) will acquire the 89% of partner Icagen Inc. (NASDAQ:ICGN)

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE